Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary objective: To confirm the efficacy of add-on therapy with LAF237 in patients with type 2 diabetes inadequately controlled with prior metformin monotherapy by testing the hypothesis that the HbA1c reduction with LAF237 is not inferior to that with gliclazide after 52 weeks of treatment.
Inclusion criteria
- Type 2 Diabetes